AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma 2026 | Nov 16–17 | London, UK

Advance forecasting, AI and analytics to drive strategic commercial decision-making across functions in Pharma The Marcus Evans AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma conference will explore how pharma leaders are embedding Gen AI for long-term forecasting, Agentic AI for Real-World-Evidence generation and advanced analytics into cross-functional workflows to improve forecasting confidence, commercial responsiveness and long-term strategic planning…

BySaurabh ChaubeyJuly 31, 2026

From Experimentation to Execution: Why Most AI Pilots in Pharma Stall

AI has moved beyond proof-of-concept on the clinical side of pharma, driving rapid discovery of new molecules. But post-market commercialization teams tell a different story: their boards are asking them to use AI to solve the problems caused by multiple rounds of layoffs, mounting pressure to do more with less, and a human capital fabric…

ByParth KhannaJune 17, 2026

THE IMPACT OF ARTIFICIAL INTELLIGENCE ON PHARMACEUTICAL AND LIFESCIENCES INDUSTRY

Abstract Just like the Internet in 1990’s, Artificial intelligence is now changing all aspects of our life and work. It’s impact is beginning to show in the industry and it is changing the life-sciences practice by fundamentally altering the way how medicines are discovered, developed, manufactured, approved, supplied and brought to market. In research and discovery, generative models and structure prediction systems shorten the path from target to lead and raise the ceiling…

ByRahul MittalMarch 24, 2026

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma 2026 | Nov 16–17 | London, UK

From Experimentation to Execution: Why Most AI Pilots in Pharma Stall

THE IMPACT OF ARTIFICIAL INTELLIGENCE ON PHARMACEUTICAL AND LIFESCIENCES INDUSTRY

Contact US

FOLLOW US